GenSight Biologics S.A. Profile Avatar - Palmy Investing

GenSight Biologics S.A.

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its pr…

Biotechnology
FR, Paris [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

GenSight Biologics S.A. has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of SIGHT.PA's Analysis
CIK: - CUSIP: F4374K117 ISIN: FR0013183985 LEI: - UEI: -
Secondary Listings
SIGHT.PA has no secondary listings inside our databases.